Scientists have uncovered a new role for the protein toll-like receptor four in the development of tissue fibrosis, or scarring. This finding has implications for the treatment of scleroderma.
Scientists have uncovered a new role for the protein toll-like receptor four in the development of tissue fibrosis, or scarring. This finding has implications for the treatment of scleroderma.